Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
416 studies found for:    Open Studies | "Carcinoma, Hepatocellular"
Show Display Options
Rank Status Study
21 Recruiting the Efficacy and Safety of Ginsenoside Rg3 Capsule in Prevention of Postoperative Recurrence of Hepatocellular Carcinoma
Conditions: Stage I Hepatocellular Carcinoma;   Stage II Hepatocellular Carcinoma
Interventions: Drug: the ginsenoside Rg3;   Drug: Placebo
22 Unknown  Environmental, Metabolic and Nutritional Factors of Hepatocellular Carcinoma in Cirrhotic Patients
Conditions: Cirrhosis With Hepatocellular Carcinoma;   Cirrhosis Without Hepatocellular Carcinoma
Interventions: Biological: Serum, plasma and DNA samples;   Procedure: Radiological exploration by CT scan or MRI
23 Recruiting A Study of LY2157299 in Participants With Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: LY2157299;   Drug: Sorafenib
24 Recruiting Circulating Tumor Cells for Hepatocellular Carcinoma
Conditions: Carcinoma, Hepatocellular;   Neoplasm Circulating Cells
Intervention:
25 Recruiting A Dose-escalation Study of Lipotecan® Plus Radiotherapy in Locally Advanced Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Drug: Lipotecan® (TLC388)
26 Recruiting Study of Regorafenib After Sorafenib in Patients With Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: Regorafenib (BAY73-4506);   Drug: Placebo
27 Recruiting Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: 5-FU;   Drug: Mitomycin;   Drug: sorafenib
28 Recruiting Phase I/II Study to Evaluate the Safety and Efficacy of Telomelysin (OBP-301) in Patients With Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Biological: OBP-301
29 Recruiting Study of Apatinib After Systemic Therapy(Chemotherapy and/or Targeted Therapy) in Patients With Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: Apatinib;   Drug: Placebo
30 Unknown  The Role of Low Molecular Weight Heparins (LMWH) Combined With Transarterial Chemoembolization (TACE) in Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: LMWH;   Procedure: TACE
31 Not yet recruiting Safety and Efficacy of Arsenic Trioxide Contained in TACE in the Treatment of HCC
Condition: Carcinoma, Hepatocellular
Interventions: Drug: TACE containing As2O3;   Drug: TACE containing placebo
32 Recruiting TACE Plus Recombinant Human Adenovirus for Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: Recombinant Human Adenovirus Type 5 Injection;   Procedure: Transartery Chemoembolization
33 Unknown  Radiofrequency Ablation With or With Transcatheter Arterial Embolization for Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Liver Cancer
Interventions: Procedure: Radiofrequency ablation;   Procedure: TACE
34 Recruiting 188RE-SSS Lipiodol to Treat HepatoCellular Carcinomas
Condition: Hepatocellular Carcinomas
Intervention: Drug: 188Re-SSS Lipiodol
35 Recruiting Comparison of Two Solvents Used With Chemotherapy Agent for Transarterial Chemoembolization of Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Other: transarterial chemoembolization(TACE);   Other: Transarterial chemoembolization (TACE)
36 Recruiting Transarterial Chemoembolization With or Without Lipiodol Chemotherapy in Patient With Unresectable Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Other: Procedure:Transarterial embolization;   Other: Procedure/Surgery: Transarterial infusion chemotherapy;   Other: Transarterial lipiodol chemotharepy
37 Recruiting TheraSphere® for Treatment of Unresectable Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Liver Cancer;   Liver Neoplasm;   Primary Liver Cancer
Intervention: Device: TheraSphere
38 Not yet recruiting TH-302 Plus Doxorubicin Delivered by Trans-Arterial Chemoembolization (TACE) in Patients With Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: Phase I Dose level -1;   Drug: Phase I dose level 1;   Drug: Phase I Dose level 2;   Drug: Phase I Dose level 3
39 Unknown  Trial of Transcatheter Arterial Chemoembolization (TACE) With Sorafenib for Locally Advanced Hepatocellular Carcinoma (HCC)
Condition: Hepatocellular Carcinoma
Interventions: Drug: Sorafenib;   Procedure: TACE (Transcatheter arterial chemoembolization)
40 Recruiting Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC)
Condition: Hepatocellular Carcinoma
Interventions: Drug: ThermoDox;   Drug: Dummy infusion

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years